Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 15, Pages 3768
Publisher
MDPI AG
Online
2022-08-03
DOI
10.3390/cancers14153768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Added Value of 18F-FDG PET/CT Compared with 68Ga-PSMA PET/CT in Patients with Castration-Resistant Prostate Cancer
- (2022) Ruohua Chen et al. JOURNAL OF NUCLEAR MEDICINE
- Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with 177Lu-PSMA therapy: a multicenter retrospective analysis
- (2022) Masatoshi Hotta et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study
- (2021) Michael J. Morris et al. CLINICAL CANCER RESEARCH
- [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
- (2021) Michael S Hofman et al. LANCET
- Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68 Ga]Ga-PSMA-11 PET/CT imaging in patients with confirmed prostate cancer
- (2021) David A. Pattison et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer
- (2021) Sander Jentjens et al. EUROPEAN RADIOLOGY
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
- (2021) Oliver Sartor et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
- (2021) Rang Wang et al. Frontiers in Oncology
- Intraindividual comparison of [68 Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007 in prostate cancer patients: a retrospective single-center analysis
- (2021) Sebastian Hoberück et al. EJNMMI Research
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- Lu177‐ PSMA therapy for men with advanced prostate cancer: Initial 18 months experience at a single Australian tertiary institution
- (2019) Rhiannon McBean et al. Journal of Medical Imaging and Radiation Oncology
- Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure after Radical Prostatectomy for Prostate Cancer
- (2019) Steven P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Matched-pair comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy
- (2019) Isabel Rauscher et al. JOURNAL OF NUCLEAR MEDICINE
- Gallium-68–Labeled Prostate-Specific Membrane Antigen–11 PET/CT of Prostate and Nonprostate Cancers
- (2019) Saabry Osmany et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Prospective Comparison of PET Imaging with PSMA-targeted 18F-DCFPyL versus Na18F for Bone Lesion Detection in Patients with Metastatic Prostate Cancer
- (2019) Steven P. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Head- to head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard.
- (2019) Jonathan Kuten et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer
- (2019) Urs J. Muehlematter et al. RADIOLOGY
- Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks
- (2019) Sazan Rasul et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
- (2019) Sofia Vaz et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intraindividual comparison of 18F-PSMA-1007 with renally excreted PSMA ligands for PSMA-PET imaging in patients with relapsed prostate cancer
- (2019) Felix Dietlein et al. JOURNAL OF NUCLEAR MEDICINE
- Response prediction of 177Lu-PSMA-617 RLT using PSA, Chromogranin A, and LDH.
- (2019) Hendrik Rathke et al. JOURNAL OF NUCLEAR MEDICINE
- Response assessment using [ 68 Ga]Ga‐PSMA ligand PET in patients undergoing systemic therapy for metastatic castration‐resistant prostate cancer
- (2019) Bernhard Grubmüller et al. PROSTATE
- Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?
- (2019) Chiara Pozzessere et al. Current Urology Reports
- Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases
- (2018) Albert Chau et al. CLINICAL NUCLEAR MEDICINE
- Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis
- (2018) Sangwon Han et al. EUROPEAN UROLOGY
- 68Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study
- (2018) Mikhail Kesler et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA-HBED-CC uptake in cervical, coeliac and sacral ganglia as an important pitfall in prostate cancer PET imaging
- (2018) Christoph Rischpler et al. JOURNAL OF NUCLEAR MEDICINE
- Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer
- (2018) Sonya Youngju Park et al. RADIOLOGY
- Integrated 68Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging
- (2018) Mohammad Al-Bayati et al. UROLOGIA INTERNATIONALIS
- Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
- (2018) Bernhard Grubmüller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
- (2017) Kambiz Rahbar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
- (2017) B. Grubmüller et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
- (2017) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
- (2017) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
- (2016) Kambiz Rahbar et al. CLINICAL NUCLEAR MEDICINE
- 18F-FACBC (anti1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) versus 11C-choline PET/CT in prostate cancer relapse: results of a prospective trial
- (2016) Cristina Nanni et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI
- (2016) Martin T. Freitag et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
- (2016) Matthias Eiber et al. EUROPEAN UROLOGY
- 68Ga-PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer
- (2016) Annika Herlemann et al. EUROPEAN UROLOGY
- 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer
- (2016) W. P. Fendler et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
- (2016) Thomas A. Hope et al. JOURNAL OF NUCLEAR MEDICINE
- Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177 Lu-PSMA-617
- (2016) Justin Ferdinandus et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
- (2016) Tobias Maurer et al. JOURNAL OF UROLOGY
- Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
- (2016) Hojjat Ahmadzadehfar et al. Oncotarget
- Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy
- (2015) J. J. Morigi et al. JOURNAL OF NUCLEAR MEDICINE
- Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
- (2015) Hojjat Ahmadzadehfar et al. EJNMMI Research
- Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer
- (2014) Jose D. Murga et al. PROSTATE
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
- (2012) TIANCHENG LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy
- (2010) Chiara Fuccio et al. ANNALS OF NUCLEAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started